Qualitative study on experiences of COPD patients on ICU admission because of exacerbation and the impact on quality of life.

Qualitative study on experiences of COPD patients on ICU admission because of exacerbation and the impact on quality of life. - The ICU QOL-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41178

Enrollment

Registered

2014-06-05

Start date

2014-07-09

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD and Chronic Obstructive Pulmonary Disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion: 1. Patients who have had a ICU admission in the period from September 2012 to January 2014; 2. Patients whose ICU admission indication was exacerbation of COPD; 3. Patients who are able to speak in understandable Dutch.

Exclusion criteria

Exclusion criteria: Exclusion: 1. Patients with severe psychiatric morbidity, noticeable in the personal file of the patients. The interview may be stressful for this group.

Design outcomes

Primary

Measure	Time frame
Het primary outcome measure consists of answering the question: how do COPD patients experience intensive care unit admission because of exacerbation and what is the impact on their quality of life?	—

Secondary

Measure	Time frame
The secundary outcome measure consists of answering the questions: 1. What are the experiences of patients with ICU admission because of exacerbation of COPD? 2. What is the impact of this ICU admission on the quality of life in people with COPD? 3. How did patients experience the treatment during ICU admission? 4. How do patients experience the information about possible ICU admission and treatment?	—

Measure

Time frame

The secundary outcome measure consists of answering the questions: 1. What are the experiences of patients with ICU admission because of exacerbation of COPD? 2. What is the impact of this ICU admission on the quality of life in people with COPD? 3. How did patients experience the treatment during ICU admission? 4. How do patients experience the information about possible ICU admission and treatment?

—

Countries

Netherlands

Outcome results